These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17017092)

  • 21. [Neurohumoral regulation of blood pressure in rheumatic patients].
    Shilkina NP; Stoliarova SA; Iunonin IE; Driazhenkova IV
    Ter Arkh; 2009; 81(6):37-41. PubMed ID: 19663191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of aldosterone with obesity-related hypertension and the metabolic syndrome.
    Vogt B; Bochud M; Burnier M
    Semin Nephrol; 2007 Sep; 27(5):529-37. PubMed ID: 17868790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension, kidney, and transgenics: a fresh perspective.
    Mullins LJ; Bailey MA; Mullins JJ
    Physiol Rev; 2006 Apr; 86(2):709-46. PubMed ID: 16601272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity-hypertension: an ongoing pandemic.
    Francischetti EA; Genelhu VA
    Int J Clin Pract; 2007 Feb; 61(2):269-80. PubMed ID: 17263714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms in the renin-angiotensin system confer increased risk of stroke independently of blood pressure: a nested case-control study.
    Möllsten A; Stegmayr B; Wiklund PG
    J Hypertens; 2008 Jul; 26(7):1367-72. PubMed ID: 18551012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newly developed angiotensin II-infused experimental models in vascular biology.
    Qin Z
    Regul Pept; 2008 Oct; 150(1-3):1-6. PubMed ID: 18562020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Function of dynamically stimulated endothelium and renin-angiotensin-aldosterone system in normotensive subjects with a family history of hypertension.
    Usalan C; Buyukhatipoglu H; Tiryaki O; Sahin A
    Nephrology (Carlton); 2008 Dec; 13(8):689-93. PubMed ID: 19154322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Energy-dependent pathogenesis in chronic hypertension].
    Postnov IuV
    Arkh Patol; 2009; 71(4):3-11. PubMed ID: 19824421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prehypertensive renin-angiotensin-aldosterone system blockade in spontaneously hypertensive rats ameliorates the loss of long-term vascular function.
    Baumann M; Megens R; Bartholome R; Dolff S; van Zandvoort MA; Smits JF; Struijker-Boudier HA; De Mey JG
    Hypertens Res; 2007 Sep; 30(9):853-61. PubMed ID: 18037779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of exercise on haemodynamic function in relation to the familial hypertension risk model.
    Hamer M
    J Hum Hypertens; 2006 May; 20(5):313-9. PubMed ID: 16496017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of sympathetic nerve activity and arterial endothelial function in pathogenesis of hypertension in patients with obstructive sleep apnea-hypopnea syndrome].
    Zhang J; Chen BY; Han JY; Cao J; Guo MN; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):437-41. PubMed ID: 17673017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models.
    Nuyt AM
    Clin Sci (Lond); 2008 Jan; 114(1):1-17. PubMed ID: 18047465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertension and obstructive sleep apnoea].
    Gjørup PH; Hedner J
    Ugeskr Laeger; 2009 Jun; 171(25):2091-4. PubMed ID: 19671387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
    Qian C; Schoemaker RG; van Gilst WH; Roks AJ
    Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.